IQVIA™ Real-World Insights Bibliography

Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan
Author(s): Toyomi Kamesaki 1, Jun-Ichi Nishimura 2, Hideho Wada 3, Eric Yu 4, Elisa Tsao 5, Jaime Morales 5, Yuzuru Kanakura 2 6 (rwesheorj 4)
Affiliations(s): 1) Division of Support in Community Medicine, Center for Community Medicine, Regional Medical Center, Center for Regional Medical Care, Jichi Medical University, 3311 - 1 Yakushiji Shimotsuke-shi, Tochigi, Japan 2) Osaka University, Osaka, Japan 3) Kawasaki Medical School, Kurashiki, Japan 4) IQVIA Solutions K.K., Tokyo, Japan 5) Sanofi, Waltham, MA, USA 6) Sumitomo Hospital, Osaka, Japan
Publication(s):  International Journal of Hematology
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Rare Diseases,
2020
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Evidence synthesis in pulmonary arterial hypertension: a systematic review and critical appraisal
Author(s): Max Schlueter, Amélie Beaudet, Evan Davies, Binu Gurung, Andreas Karabis
Affiliations(s): IQVIA, 210 Pentonville Road, London, N1 9JY; IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, Netherlands; Department of Statistical Science, University College London, London, WC1E 6BT, UK.
Publication(s): 
Document Type(s): Article,
Countries: 
Click here for the abstract
C:
Y:
Comparative Effectiveness & Health Technology Assessment, Methodology, Rare Diseases,
2020
  L:
A:
English
Literature Review, Review,
  Add to report
 
 
A network meta analysis comparing C1 and kallikrein inhibitors approved for prophylaxis of hereditary angioedema in the United States
Author(s): P. Saharia1, P. Soni2, M. Chatterjee3
Affiliations(s): IQVIA, Gurugram, HR, India; IQVIA, Delhi, India; IQVIA, Gurugram, India
Publication(s):  DOI: https://doi.org/10.1016/j.jval.2019.04.1641
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Cardiovascular disease, Rare Diseases,
2019
  L:
A:
English
Literature Review, Meta analysis,
  Add to report
 
 
WHAT INTERPRETATION OF ICERS IN ORPHAN DISEASES? A FRENCH EXAMPLE.
Author(s): Moutier Hélène; Bourguignon Sandrine; Maurel Frédérique; Bodaghi Charles
Affiliations(s): RWI IQVIA France
Publication(s):  ISPOR 2018
Document Type(s): Poster,
Countries: France,
C:
Y:
Comparative Effectiveness & Health Technology Assessment, Health economics, Pricing and reimbursement, Rare Diseases,
2018
  L:
A:
English
Cost effectiveness, Pricing & Reimbursement, Willingness to pay,
  Add to report
 
 
Rare disease development programs: An update
Author(s): Wu J, Want C, Horton DB, Petersen I, Oliveria S, Blackburn S, Jiang J, LoCasale R.
Affiliations(s): 
Publication(s):  Pharmacoepidemiol Drug Saf 2018; 27 (2):5.
Document Type(s): Poster,
Countries: 
C:
Y:
Rare Diseases,
2018
  L:
A:
English
  Add to report
 
 
Identification of a hereditary angioedema cohort in a US ambulatory EMR database
Author(s): Brouwer E, Bratton E, Near A, Lang K, Mack C
Affiliations(s): 
Publication(s):  Pharmacoepidemiol Drug Saf 2018; 27 (2): 136-137.
Document Type(s): Poster,
Countries: 
C:
Y:
Rare Diseases,
2018
  L:
A:
English
  Add to report
 
 
Studies on economic burden of disease using real-world healthcare data in Japan: a systematic review
Author(s): WY Kuan 1, Sven Demiya 1, Eric Yu 1, Y Piao 1 (rwesheorj 1)
Affiliations(s): 1) IQVIA Solutions Japan K.K., Tokyo, Japan
Publication(s):  ISPOR Asia Pacific 2018 Conference
Document Type(s): Abstract,
Countries: Japan,
Click here for the abstract
C:
Y:
Rare Diseases,
2018
  L:
A:
English
Economic evaluation, Literature Review,
  Add to report
 
 
Healthcare resource utilization and costs associated with long-term corticosteroid exposure in patients with systemic lupus erythematosus
Author(s): Kabadi S, Yeaw J, Bacani AK, Tafesse E, Bos K, Karkare S, DeKoven M, Vina ER
Affiliations(s): AstraZeneca, IQVIA
Publication(s):  Lupus
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Rare Diseases,
2018
  L:
A:
English
Cost analysis, Retrospective cohort analysis,
  Add to report
 
 
Health Care Resource Utilization Among a US Cohort Treated for Hereditary Angioedema, 2010?2015
Author(s): Tachdjian R, Johnson KE, Casso D, Oliveria SA, Devercelli G, Jain G.
Affiliations(s): Tachdjian R: UCLA School of Medicine; Johnson KE: IQVIA (formerly); Casso D: IQVIA; Oliveria SA: IQVIA; Devercelli G: Shire; Jain G: Shire
Publication(s):  2018 American Academy of Allergy, Asthma and Immunology (AAAAI)/World Allergy Organization (WAO) Joint Congress
Document Type(s): Poster,
Countries: USA,
C:
Y:
Patient Registries & Real-World Study Methods, Rare Diseases,
2018
  L:
A:
English
Cost analysis, Database Study, Epidemiological study, Retrospective database analysis,
  Add to report
 
 
Demographic Characteristics and Treatment Patterns among Patients Treated for Hereditary Angioedema in a U.S. Cohort, 2006-2015
Author(s): Tachdjian R, Johnson KE, Casso D, Oliveria SA, Devercelli G, Jain G
Affiliations(s): Tachdjian R: UCLA School of Medicine (Department of Medicine and Pediatrics), Johnson KE: IQVIA (formerly); Casso D: IQVIA; Oliveria SA: IQVIA; Devercelli G: Shire; Jain G: Shire.
Publication(s):  34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Document Type(s): Abstract,
Countries: USA,
C:
Y:
Rare Diseases,
2018
  L:
A:
English
Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis,
  Add to report
 
 
 1 of 2 Next Page Last Page